BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Large Growth in Short Interest

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 715,900 shares, a growth of 205.8% from the February 13th total of 234,100 shares. Based on an average daily trading volume, of 390,000 shares, the days-to-cover ratio is presently 1.8 days. Approximately 14.3% of the shares of the company are sold short.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in BioRestorative Therapies stock. Citadel Advisors LLC purchased a new position in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned about 0.31% of BioRestorative Therapies as of its most recent SEC filing. 69.38% of the stock is owned by institutional investors.

BioRestorative Therapies Stock Up 0.3 %

NASDAQ:BRTX opened at $1.60 on Thursday. The stock’s 50 day moving average price is $1.96 and its 200 day moving average price is $1.71. The company has a market capitalization of $11.07 million, a PE ratio of -1.05 and a beta of 64.37. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.